Guangdong Provincial Maternal and Child Health Hospital

The Pediatric Surgery Department of Guangdong Women and Children Hospital is a Guangdong Provincial Clinical Key Specialty integrating medical care, teaching and research. With strong technical strength, it runs subspecialties such as pediatric general surgery, pediatric urology, pediatric oncology and pediatric thoracic surgery. It is at an advanced level in China in neonatal surgery, pediatric minimally invasive surgery and management of difficult diseases, being one of the earliest units in Guangdong to carry out pediatric minimally invasive surgery.

Founded in 1981, this is China's first prenatal diagnosis center integrating genetic counseling and laboratory work. As a Guangdong Provincial Medical Key Discipline, it has cytogenetics, molecular and biochemical immunology laboratories and a joint laboratory with Harvard Medical School. It leads the establishment of a birth-defect prevention network covering more than 130 hospitals across the province, at the forefront of the industry in thalassemia diagnosis and treatment and intrauterine fetal therapy.

The Child Health Department of Guangdong Women and Children Hospital was founded in 1982, with a high-level expert team led by Professor Wu Jieling. It has been awarded the National Demonstration Base for Early Childhood Development and is among the first national-level special neonate health specialties in China. It focuses on children's growth and development assessment, psycho-behavioral intervention and high-risk infant management, and is a top child health center in South China.

Established in 1998, this is a multidisciplinary collaboration center integrating prevention, diagnosis and treatment, translational medicine and teaching. It pioneered China's "quadruple breast cancer early diagnosis technique", with early breast cancer detection rates at a leading level in China, and annual outpatient volume and surgical volume among the province's top.

Established in 2000, this is one of the earliest centers to obtain Ministry of Health approval for human assisted reproductive technology. With more than 80 medical staff, it carries out husband/sperm donor artificial insemination and first, second and third-generation IVF technologies. The IVF clinical pregnancy rate reaches about 60%, at a leading level domestically and internationally. It owns Guangdong's first reproductive ward and is the vice-chairman unit of the ART Monitoring and Evaluation Branch of the China Maternal and Child Health Association.

Founded in 1993, it has 200 beds and treats over 8,000 critically ill newborns a year. As the Guangdong Provincial Newborn Critical Care Medical Quality Control Center, it possesses core technologies including very low birth weight infant rescue, mild hypothermia therapy and CRRT, with a transport network covering the whole province, and comprehensive strength among the top in China.